ReviewPharmacoEconomics2016

The Clinical and Cost Effectiveness of Vortioxetine for the Treatment of a Major Depressive Episode in Patients With Failed Prior Antidepressant Therapy: A Critique of the Evidence.

James Lomas et al.PubMed ↗Publisher ↗

No numbers read from the abstract.